img

Global Pharmaceutical CMO Services Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmaceutical CMO Services Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Pharmaceutical CMO Services market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Active Pharmaceutical Ingredients (APIs) accounting for % of the Pharmaceutical CMO Services global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Pharmaceutical Industry segment is altered to an % CAGR throughout this forecast period.
The global key companies of Pharmaceutical CMO Services include Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals, AbbVie, Pfizer, Evonik Health Care, Delpharm and Recipharm, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Pharmaceutical CMO Services market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Pharmaceutical CMO Services landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Pharmaceutical CMO Services market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Pharmaceutical CMO Services market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Pharmaceutical CMO Services market. Readers of the report can become informed about current and future trends of the global Pharmaceutical CMO Services market and how they will impact market growth during the forecast period.



By Company


Lonza
Boehringer Ingelheim
FUJIFILM Diosynth Biotechnologies
AGC Chemicals
AbbVie
Pfizer
Evonik Health Care
Delpharm
Recipharm
Teva API
Catalent
Esteve Quimica
Fareva
Patheon
Piramal
Hisun Pharmaceuticals
Segment by Type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Packaging

Segment by Application


Pharmaceutical Industry
Biotechnology Industry
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Pharmaceutical CMO Services in global and regional level.
Chapter 3Detailed analysis of Pharmaceutical CMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CMO Services revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.2.4 Packaging
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO Services Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Pharmaceutical CMO Services Market Size (2018-2034)
2.2 Pharmaceutical CMO Services Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Pharmaceutical CMO Services Market Size by Region (2018-2024)
2.4 Global Pharmaceutical CMO Services Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Pharmaceutical CMO Services Countries Ranking by Market Size
3 Pharmaceutical CMO Services Competitive by Company
3.1 Global Pharmaceutical CMO Services Revenue by Players
3.1.1 Global Pharmaceutical CMO Services Revenue by Players (2018-2024)
3.1.2 Global Pharmaceutical CMO Services Market Share by Players (2018-2024)
3.2 Global Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Pharmaceutical CMO Services Revenue
3.4 Global Pharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO Services Revenue in 2022
3.5 Global Key Players of Pharmaceutical CMO Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical CMO Services, Product and Application
3.7 Global Key Players of Pharmaceutical CMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pharmaceutical CMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CMO Services Historic Revenue by Type (2018-2024)
4.2 Global Pharmaceutical CMO Services Forecasted Revenue by Type (2024-2034)
5 Global Pharmaceutical CMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2018-2024)
5.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pharmaceutical CMO Services Revenue by Company (2021-2024)
6.2 North America Pharmaceutical CMO Services Revenue by Type (2018-2034)
6.3 North America Pharmaceutical CMO Services Revenue by Application (2018-2034)
6.4 North America Pharmaceutical CMO Services Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Revenue by Company (2021-2024)
7.2 Europe Pharmaceutical CMO Services Revenue by Type (2018-2034)
7.3 Europe Pharmaceutical CMO Services Revenue by Application (2018-2034)
7.4 Europe Pharmaceutical CMO Services Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Pharmaceutical CMO Services Revenue by Company (2021-2024)
8.2 Asia Pacific Pharmaceutical CMO Services Revenue by Type (2018-2034)
8.3 Asia Pacific Pharmaceutical CMO Services Revenue by Application (2018-2034)
8.4 Asia Pacific Pharmaceutical CMO Services Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Revenue by Company (2021-2024)
9.2 Latin America Pharmaceutical CMO Services Revenue by Type (2018-2034)
9.3 Latin America Pharmaceutical CMO Services Revenue by Application (2018-2034)
9.4 Latin America Pharmaceutical CMO Services Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical CMO Services Revenue by Company (2021-2024)
10.2 Middle East and Africa Pharmaceutical CMO Services Revenue by Type (2018-2034)
10.3 Middle East and Africa Pharmaceutical CMO Services Revenue by Application (2018-2034)
10.4 Middle East and Africa Pharmaceutical CMO Services Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical CMO Services Products and Services
11.1.4 Lonza Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.1.5 Lonza Pharmaceutical CMO Services SWOT Analysis
11.1.6 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Products and Services
11.2.4 Boehringer Ingelheim Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.2.5 Boehringer Ingelheim Pharmaceutical CMO Services SWOT Analysis
11.2.6 Boehringer Ingelheim Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Products and Services
11.3.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services SWOT Analysis
11.3.6 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 AGC Chemicals
11.4.1 AGC Chemicals Company Details
11.4.2 AGC Chemicals Business Overview
11.4.3 AGC Chemicals Pharmaceutical CMO Services Products and Services
11.4.4 AGC Chemicals Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.4.5 AGC Chemicals Pharmaceutical CMO Services SWOT Analysis
11.4.6 AGC Chemicals Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceutical CMO Services Products and Services
11.5.4 AbbVie Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.5.5 AbbVie Pharmaceutical CMO Services SWOT Analysis
11.5.6 AbbVie Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Pharmaceutical CMO Services Products and Services
11.6.4 Pfizer Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.6.5 Pfizer Pharmaceutical CMO Services SWOT Analysis
11.6.6 Pfizer Recent Development
11.7 Evonik Health Care
11.7.1 Evonik Health Care Company Details
11.7.2 Evonik Health Care Business Overview
11.7.3 Evonik Health Care Pharmaceutical CMO Services Products and Services
11.7.4 Evonik Health Care Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.7.5 Evonik Health Care Pharmaceutical CMO Services SWOT Analysis
11.7.6 Evonik Health Care Recent Development
11.8 Delpharm
11.8.1 Delpharm Company Details
11.8.2 Delpharm Business Overview
11.8.3 Delpharm Pharmaceutical CMO Services Products and Services
11.8.4 Delpharm Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.8.5 Delpharm Pharmaceutical CMO Services SWOT Analysis
11.8.6 Delpharm Recent Development
11.9 Recipharm
11.9.1 Recipharm Company Details
11.9.2 Recipharm Business Overview
11.9.3 Recipharm Pharmaceutical CMO Services Products and Services
11.9.4 Recipharm Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.9.5 Recipharm Pharmaceutical CMO Services SWOT Analysis
11.9.6 Recipharm Recent Development
11.10 Teva API
11.10.1 Teva API Company Details
11.10.2 Teva API Business Overview
11.10.3 Teva API Pharmaceutical CMO Services Products and Services
11.10.4 Teva API Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.10.5 Teva API Pharmaceutical CMO Services SWOT Analysis
11.10.6 Teva API Recent Development
11.11 Catalent
11.11.1 Catalent Company Details
11.11.2 Catalent Business Overview
11.11.3 Catalent Pharmaceutical CMO Services Products and Services
11.11.4 Catalent Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.11.5 Catalent Recent Development
11.12 Esteve Quimica
11.12.1 Esteve Quimica Company Details
11.12.2 Esteve Quimica Business Overview
11.12.3 Esteve Quimica Pharmaceutical CMO Services Products and Services
11.12.4 Esteve Quimica Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.12.5 Esteve Quimica Recent Development
11.13 Fareva
11.13.1 Fareva Company Details
11.13.2 Fareva Business Overview
11.13.3 Fareva Pharmaceutical CMO Services Products and Services
11.13.4 Fareva Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.13.5 Fareva Recent Development
11.14 Patheon
11.14.1 Patheon Company Details
11.14.2 Patheon Business Overview
11.14.3 Patheon Pharmaceutical CMO Services Products and Services
11.14.4 Patheon Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.14.5 Patheon Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical CMO Services Products and Services
11.15.4 Piramal Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.15.5 Piramal Recent Development
11.16 Hisun Pharmaceuticals
11.16.1 Hisun Pharmaceuticals Company Details
11.16.2 Hisun Pharmaceuticals Business Overview
11.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Products and Services
11.16.4 Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024)
11.16.5 Hisun Pharmaceuticals Recent Development
12 Pharmaceutical CMO Services Market Dynamics
12.1 Pharmaceutical CMO Services Industry Trends
12.2 Pharmaceutical CMO Services Market Drivers
12.3 Pharmaceutical CMO Services Market Challenges
12.4 Pharmaceutical CMO Services Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical CMO Services Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Active Pharmaceutical Ingredients (APIs)
Table 3. Key Players of Finished Dose Formulations (FDFs)
Table 4. Key Players of Packaging
Table 5. Global Pharmaceutical CMO Services Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Pharmaceutical CMO Services Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 7. Global Pharmaceutical CMO Services Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Pharmaceutical CMO Services Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 9. Global Pharmaceutical CMO Services Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 10. Global Pharmaceutical CMO Services Revenue by Players (2018-2024) & (US$ Million)
Table 11. Global Pharmaceutical CMO Services Market Share by Players (2018-2024)
Table 12. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2022)
Table 13. Ranking of Global Top Pharmaceutical CMO Services Companies by Revenue (US$ Million) in 2022
Table 14. Global 5 Largest Players Market Share by Pharmaceutical CMO Services Revenue (CR5 and HHI) & (2018-2024)
Table 15. Global Key Players of Pharmaceutical CMO Services, Headquarters and Area Served
Table 16. Global Key Players of Pharmaceutical CMO Services, Product and Application
Table 17. Global Key Players of Pharmaceutical CMO Services, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Pharmaceutical CMO Services Market Size by Type (2018-2024) & (US$ Million)
Table 20. Global Pharmaceutical CMO Services Revenue Market Share by Type (2018-2024)
Table 21. Global Pharmaceutical CMO Services Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 22. Global Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Table 23. Global Pharmaceutical CMO Services Market Size by Application (2018-2024) & (US$ Million)
Table 24. Global Pharmaceutical CMO Services Revenue Market Share by Application (2018-2024)
Table 25. Global Pharmaceutical CMO Services Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 26. Global Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Table 27. North America Pharmaceutical CMO Services Revenue by Company (2021-2024) & (US$ Million)
Table 28. North America Pharmaceutical CMO Services Revenue by Type (2018-2024) & (US$ Million)
Table 29. North America Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 30. North America Pharmaceutical CMO Services Revenue by Application (2018-2024) & (US$ Million)
Table 31. North America Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 32. North America Pharmaceutical CMO Services Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Pharmaceutical CMO Services Revenue by Country (2018-2024) & (US$ Million)
Table 34. North America Pharmaceutical CMO Services Revenue by Country (2024-2034) & (US$ Million)
Table 35. Europe Pharmaceutical CMO Services Revenue by Company (2021-2024) & (US$ Million)
Table 36. Europe Pharmaceutical CMO Services Revenue by Type (2018-2024) & (US$ Million)
Table 37. Europe Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 38. Europe Pharmaceutical CMO Services Revenue by Application (2018-2024) & (US$ Million)
Table 39. Europe Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 40. Europe Pharmaceutical CMO Services Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Europe Pharmaceutical CMO Services Revenue by Country (2018-2024) & (US$ Million)
Table 42. Europe Pharmaceutical CMO Services Revenue by Country (2024-2034) & (US$ Million)
Table 43. Asia Pacific Pharmaceutical CMO Services Revenue by Company (2021-2024) & (US$ Million)
Table 44. Asia Pacific Pharmaceutical CMO Services Revenue by Type (2018-2024) & (US$ Million)
Table 45. Asia Pacific Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 46. Asia Pacific Pharmaceutical CMO Services Revenue by Application (2018-2024) & (US$ Million)
Table 47. Asia Pacific Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical CMO Services Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 49. Asia Pacific Pharmaceutical CMO Services Revenue by Region (2018-2024) & (US$ Million)
Table 50. Asia Pacific Pharmaceutical CMO Services Revenue by Region (2024-2034) & (US$ Million)
Table 51. Latin America Pharmaceutical CMO Services Revenue by Company (2021-2024) & (US$ Million)
Table 52. Latin America Pharmaceutical CMO Services Revenue by Type (2018-2024) & (US$ Million)
Table 53. Latin America Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 54. Latin America Pharmaceutical CMO Services Revenue by Application (2018-2024) & (US$ Million)
Table 55. Latin America Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 56. Latin America Pharmaceutical CMO Services Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 57. Latin America Pharmaceutical CMO Services Revenue by Country (2018-2024) & (US$ Million)
Table 58. Latin America Pharmaceutical CMO Services Revenue by Country (2024-2034) & (US$ Million)
Table 59. Middle East and Africa Pharmaceutical CMO Services Revenue by Company (2021-2024) & (US$ Million)
Table 60. Middle East and Africa Pharmaceutical CMO Services Revenue by Type (2018-2024) & (US$ Million)
Table 61. Middle East and Africa Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Pharmaceutical CMO Services Revenue by Application (2018-2024) & (US$ Million)
Table 63. Middle East and Africa Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Pharmaceutical CMO Services Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 65. Middle East and Africa Pharmaceutical CMO Services Revenue by Country (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Pharmaceutical CMO Services Revenue by Country (2024-2034) & (US$ Million)
Table 67. Lonza Company Details
Table 68. Lonza Business Overview
Table 69. Lonza Pharmaceutical CMO Services Product and Services
Table 70. Lonza Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 71. Lonza Pharmaceutical CMO Services SWOT Analysis
Table 72. Lonza Recent Development
Table 73. Boehringer Ingelheim Company Details
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Pharmaceutical CMO Services Product and Services
Table 76. Boehringer Ingelheim Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 77. Boehringer Ingelheim Pharmaceutical CMO Services SWOT Analysis
Table 78. Boehringer Ingelheim Recent Development
Table 79. FUJIFILM Diosynth Biotechnologies Company Details
Table 80. FUJIFILM Diosynth Biotechnologies Business Overview
Table 81. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Services
Table 82. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 83. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services SWOT Analysis
Table 84. FUJIFILM Diosynth Biotechnologies Recent Development
Table 85. AGC Chemicals Company Details
Table 86. AGC Chemicals Business Overview
Table 87. AGC Chemicals Pharmaceutical CMO Services Product and Services
Table 88. AGC Chemicals Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 89. AGC Chemicals Pharmaceutical CMO Services SWOT Analysis
Table 90. AGC Chemicals Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Pharmaceutical CMO Services Product and Services
Table 94. AbbVie Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 95. AbbVie Pharmaceutical CMO Services SWOT Analysis
Table 96. AbbVie Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Pharmaceutical CMO Services Product and Services
Table 100. Pfizer Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 101. Pfizer Pharmaceutical CMO Services SWOT Analysis
Table 102. Pfizer Recent Development
Table 103. Evonik Health Care Company Details
Table 104. Evonik Health Care Business Overview
Table 105. Evonik Health Care Pharmaceutical CMO Services Product and Services
Table 106. Evonik Health Care Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 107. Evonik Health Care Pharmaceutical CMO Services SWOT Analysis
Table 108. Evonik Health Care Recent Development
Table 109. Delpharm Company Details
Table 110. Delpharm Business Overview
Table 111. Delpharm Pharmaceutical CMO Services Product and Services
Table 112. Delpharm Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 113. Delpharm Pharmaceutical CMO Services SWOT Analysis
Table 114. Delpharm Recent Development
Table 115. Recipharm Company Details
Table 116. Recipharm Business Overview
Table 117. Recipharm Pharmaceutical CMO Services Product and Services
Table 118. Recipharm Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 119. Recipharm Pharmaceutical CMO Services SWOT Analysis
Table 120. Recipharm Recent Development
Table 121. Teva API Company Details
Table 122. Teva API Business Overview
Table 123. Teva API Pharmaceutical CMO Services Product and Services
Table 124. Teva API Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 125. Teva API Pharmaceutical CMO Services SWOT Analysis
Table 126. Teva API Recent Development
Table 127. Catalent Company Details
Table 128. Catalent Business Overview
Table 129. Catalent Pharmaceutical CMO Services Product and Services
Table 130. Catalent Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 131. Catalent Recent Development
Table 132. Esteve Quimica Company Details
Table 133. Esteve Quimica Business Overview
Table 134. Esteve Quimica Pharmaceutical CMO Services Product and Services
Table 135. Esteve Quimica Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 136. Esteve Quimica Recent Development
Table 137. Fareva Company Details
Table 138. Fareva Business Overview
Table 139. Fareva Pharmaceutical CMO Services Product and Services
Table 140. Fareva Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 141. Fareva Recent Development
Table 142. Patheon Company Details
Table 143. Patheon Business Overview
Table 144. Patheon Pharmaceutical CMO Services Product and Services
Table 145. Patheon Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 146. Patheon Recent Development
Table 147. Piramal Company Details
Table 148. Piramal Business Overview
Table 149. Piramal Pharmaceutical CMO Services Product and Services
Table 150. Piramal Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 151. Piramal Recent Development
Table 152. Hisun Pharmaceuticals Company Details
Table 153. Hisun Pharmaceuticals Business Overview
Table 154. Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Services
Table 155. Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue in Pharmaceutical CMO Services Business (2018-2024) & (US$ Million)
Table 156. Hisun Pharmaceuticals Recent Development
Table 157. Pharmaceutical CMO Services Market Trends
Table 158. Pharmaceutical CMO Services Market Drivers
Table 159. Pharmaceutical CMO Services Market Challenges
Table 160. Pharmaceutical CMO Services Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical CMO Services Product Picture
Figure 2. Global Pharmaceutical CMO Services Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Pharmaceutical CMO Services Market Share by Type: 2022 VS 2034
Figure 4. Active Pharmaceutical Ingredients (APIs) Features
Figure 5. Finished Dose Formulations (FDFs) Features
Figure 6. Packaging Features
Figure 7. Global Pharmaceutical CMO Services Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 8. Global Pharmaceutical CMO Services Market Share by Application: 2022 VS 2034
Figure 9. Pharmaceutical Industry
Figure 10. Biotechnology Industry
Figure 11. Pharmaceutical CMO Services Report Years Considered
Figure 12. Global Pharmaceutical CMO Services Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Pharmaceutical CMO Services Market Size 2018-2034 (US$ Million)
Figure 14. Global Pharmaceutical CMO Services Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global Pharmaceutical CMO Services Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Pharmaceutical CMO Services Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Pharmaceutical CMO Services Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Pharmaceutical CMO Services Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global Pharmaceutical CMO Services Market Share by Players in 2022
Figure 20. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Pharmaceutical CMO Services Revenue in 2022
Figure 22. North America Pharmaceutical CMO Services Revenue Market Share by Company in 2022
Figure 23. North America Pharmaceutical CMO Services Revenue Market Share by Type (2018-2034)
Figure 24. North America Pharmaceutical CMO Services Revenue Market Share by Application (2018-2034)
Figure 25. North America Pharmaceutical CMO Services Revenue Share by Country (2018-2034)
Figure 26. United States Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Pharmaceutical CMO Services Revenue Market Share by Company in 2022
Figure 29. Europe Pharmaceutical CMO Services Revenue Market Share by Type (2018-2034)
Figure 30. Europe Pharmaceutical CMO Services Revenue Market Share by Application (2018-2034)
Figure 31. Europe Pharmaceutical CMO Services Revenue Share by Country (2018-2034)
Figure 32. Germany Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 33. France Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Pharmaceutical CMO Services Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Pharmaceutical CMO Services Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Pharmaceutical CMO Services Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Pharmaceutical CMO Services Revenue Share by Region (2018-2034)
Figure 41. China Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 44. India Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 46. China Taiwan Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 50. Latin America Pharmaceutical CMO Services Revenue Market Share by Company in 2022
Figure 51. Latin America Pharmaceutical CMO Services Revenue Market Share by Type (2018-2034)
Figure 52. Latin America Pharmaceutical CMO Services Revenue Market Share by Application (2018-2034)
Figure 53. Latin America Pharmaceutical CMO Services Revenue Share by Country (2018-2034)
Figure 54. Mexico Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 55. Brazil Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 56. Argentina Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 57. Middle East and Africa Pharmaceutical CMO Services Revenue Market Share by Company in 2022
Figure 58. Middle East and Africa Pharmaceutical CMO Services Revenue Market Share by Type (2018-2034)
Figure 59. Middle East and Africa Pharmaceutical CMO Services Revenue Market Share by Application (2018-2034)
Figure 60. Middle East and Africa Pharmaceutical CMO Services Revenue Share by Country (2018-2034)
Figure 61. Turkey Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 63. UAE Pharmaceutical CMO Services Revenue (2018-2034) & (US$ Million)
Figure 64. Lonza Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 66. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 67. AGC Chemicals Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 68. AbbVie Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 69. Pfizer Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 70. Evonik Health Care Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 71. Delpharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 72. Recipharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 73. Teva API Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 74. Catalent Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 75. Esteve Quimica Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 76. Fareva Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 77. Patheon Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 78. Piramal Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 79. Hisun Pharmaceuticals Revenue Growth Rate in Pharmaceutical CMO Services Business (2018-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed